Airway-Therapeutics
Cincinnati, US · Founded 2011 · 16 employees on LinkedIn · 1 known investors
Find your way into Airway-Therapeutics
83 people in our graph share verified history with the Airway-Therapeutics team — schools, employers, funds. One of them is your warm intro.
Catherine Pearce, DHSc, MBAunlockedknows Marc Salzberg · together at Medpace (overlapped)
×2knows the team · via University of Basel
×7knows the team · via Università degli Studi di Milano
×2knows the team · via Medpace
Airway Therapeutics is a biotech company developing inhaled therapeutics for inflammatory and infectious lung diseases, including programs targeting bronchopulmonary dysplasia, acute respiratory distress syndrome, and pulmonary fibrosis.
Founders & leadership
Airway-Therapeutics was founded in 2011 by Marc Salzberg.
MS
Marc SalzberginFounder · Chairman, Chief Executive & Medical OfficerMarc Salzberg is an executive officer and director at Airway Therapeutics. He brings over 25 years of experience in pharmaceutical, biotechnology, and medical device development across oncology, pediatrics, and rare diseases, including work in academic settings, licensing, M&A transactions, and corporate finance.
AW
Alan WolkNamed on SEC filing
DL
Doug LoftusNamed on SEC filing
ES
Elise Scroggs PanayotopoulousNamed on SEC filing
JT
Joe TodicscoNamed on SEC filing
Board
MV
Michael VenerableBoard director
JD
Jennifer DauerBoard director
JM
John M. RiceBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$10.9M disclosed across 1 round · 2018
▶$43.5MraisedSep 2026 · 116 investors · BiotechnologyRule 506(b)
▶$43.5MraisedSep 2026 · 116 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Marc SalzbergExecutive Officer, Director
- Alan WolkExecutive Officer, Director
- Doug LoftusDirector
- Elise Scroggs PanayotopoulousDirector
- Joe TodicscoDirector
- Offering amount
- $50.6M
- Amount sold
- $43.5M
- First sale
- Aug 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.9MraisedMar 2018 · 39 investors · BiotechnologyRule 506(b)
▶$10.9MraisedMar 2018 · 39 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jennifer DauerDirector
- Marc SalzbergExecutive Officer, Director
- John M. RiceDirector
- Michael VenerableDirector
- Offering amount
- $11M
- Amount sold
- $10.9M
- Proceeds to insiders
- $245K
- First sale
- Mar 2018
- Incorporated
- Limited Liability Company, Ohio
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Aer Therapeutics7 shared keywordsAer Therapeutics develops a science-driven therapeutic aimed at eliminating mucus plugs in the lungs to treat muco-obstructive lung diseases such as COPD and asthma. The company focuses on respiratory care for patients with these conditions.
Apogee Therapeutics6 shared keywordsApogee Therapeutics develops engineered antibody therapies to treat inflammatory and immune diseases with reduced injection frequency compared to existing treatments.
Seamless5 shared keywordsSeamless is a revenue operations platform that uses AI to automate sales outreach and contact verification for sales, marketing, and customer success teams. It identifies target buyers, verifies contact information in real time, and orchestrates multi-channel outreach via email, phone, and social media to generate meetings and pipeline.
Companies competing with Airway-Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Airway-Therapeutics do?
- Airway Therapeutics is a biotech company developing inhaled therapeutics for inflammatory and infectious lung diseases, including programs targeting bronchopulmonary dysplasia, acute respiratory distress syndrome, and pulmonary fibrosis.
- Who founded Airway-Therapeutics?
- Airway-Therapeutics was founded by Marc Salzberg in 2011.
- Who are Airway-Therapeutics's investors?
- Airway-Therapeutics's investors include CincyTech.
- How much funding has Airway-Therapeutics raised?
- Airway-Therapeutics has disclosed $10.9M raised across 1 round.
- Where is Airway-Therapeutics headquartered?
- Airway-Therapeutics is headquartered in Cincinnati, US.